Skip to content

EXOZ EXOZ Licensed Product — Cumulative Net Sales

Similar metrics at other companies

SOL
SOLSProducts — Net Sales
$915M+9.2%
Diebold Nixdorf logo
DBDProducts — Net Sales
$355M+6.7%
Insight Enterprises logo
NSITProducts — Total Net Sales
$1.67B-2.4%
Balchem logo
BCPCProduct Sales Revenue — Net Sales
$270.22M+8.1%
Enerpac Tool Group logo
EPACProducts — Net Sales
$125.31M+10.0%
Honeywell International logo
HONProduct — Net Sales
64%-1.0pp

Other financials

Income statement

See full
Revenue$17.5K
Operating income-$2.4M-22.4%
Net income-$2.4M-27.7%
EPS (diluted)-$0.28-27.3%

Balance sheet

See full
Cash & equivalents$1.4M-83.0%
Total debt$1.2M-8.8%
Total equity$1.5M-82.8%
Total assets$4.0M-65.1%

Cash flow

See full
Operating cash flow-$1.5M-34.5%
CapEx$57.6K+85.5%
Free cash flow-$1.6M-35.8%

Valuation

See full
Market cap$76.8M-5.6%
Enterprise value$76.57M+1.0%
P/S1,096.1×

Profitability

See full
Operating margin-14,489.6%
Net margin-2,909.1%
FCF margin-10,117.8%

Returns & leverage

See full
Return on equity-185.8%
Debt / equity0.8×+0.6×
Current ratio1.3×-5.2×

Where this comes from

Reported directly by EXOZ in its filing.

Tagged under the XBRL concept EXOZ:CumulativeNetSales.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's licensed product — cumulative net sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EXOZ's licensed product — cumulative net sales?
EXOZ (EXOZ) reported licensed product — cumulative net sales of $1M in Q1 2026.
How has EXOZ's licensed product — cumulative net sales changed year-over-year?
EXOZ's licensed product — cumulative net sales decreased by 0.0% year-over-year, from $1M to $1M.
What does licensed product — cumulative net sales mean?
This metric tracks the total aggregate revenue generated from the sale of products or services within a specific business segment since the inception of the product line or the start of the reporting period. It serves as a key indicator of the long-term market adoption, commercial viability, and revenue-generating potential of the segment's offerings. By analyzing cumulative performance, stakeholders can evaluate the historical success and scaling trajectory of the product relative to its initial development and acquisition costs.